You are here

afami-cel

FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor

Fierce Pharma

Fri, 08/2/24 - 11:32 am

synovial sarcoma

5 FDA Decisions to Watch in the Second Half of 2024

BioSpace

Mon, 06/24/24 - 11:29 am

Alzheimer's disease

advanced synovial sarcoma

Lykos Therapeutics

Bristol Myers Squibb

non-small cell lung cancer

5 Cell and Gene Therapy Decisions to Watch in 2024

BioSpace

Mon, 04/22/24 - 11:38 am

Abeona Therapeutics

recessive dystrophic epidermolysis bullosa

Rocket Pharmaceuticals

Leukocyte adhesion deficiency-1

advanced synovial sarcoma

Autolus Therapeutics

B cell acute lymphoblastic leukemia